A role of multifactorial evaluation of prostatic 3t MRI in patients with elevated prostatic-specific antigen levels: Prospective comparison with ultrasound-guided transrectal biopsy

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2791-2796

  Ferda, Jirí ^a   Kastner, Jan ^a   Hora, Milan ^a   Hes, Ondrej ^a   Fínek, Jindrich ^a   Topolcan, Ondrej ^a   Kreuzberg, Boris ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

3T magnetic resonance; Prostatic carcinoma; PSA; Transrectal biopsy

Indexed keywords

CHOLINE; CREATINE; GADOBENATE DIMEGLUMINE; PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD VOLUME; CALCULATION; CANCER DIAGNOSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIFACTORIAL INHERITANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN SATURATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE CARCINOMA; RECTUM BIOPSY; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; ULTRASOUND GUIDED TRANSRECTAL BIOPSY; 3T MAGNETIC RESONANCE; AGED; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; ENDOSCOPIC ECHOGRAPHY; IMAGE GUIDED BIOPSY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PSA; TRANSRECTAL BIOPSY;

3T MAGNETIC RESONANCE; PROSTATIC CARCINOMA; PSA; TRANSRECTAL BIOPSY;

AGED; COHORT STUDIES; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

MLCS; MLOWN;

EID: 84881367116     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Roehl KA, Antenor JA and Catalona WJ: Serial biopsy results in prostate cancer screening study. J Urol 167: 2435-2439, 2002.
2. Franiel T, Hamm B and Hricag H: Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 21: 6116-6126, 2011.
3. Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, Susani M, Haitel A, Jaromi S, Ngo L and Rofsky NM: Prostate cancer: accurate determination of extracapsular extention with high-spatial-resolution dynamic contrastenhanced and T2 weighted MR imaging: intitial results. Radiology 245: 176-185, 2007.
4. Scheenen TW, Heijmink SW, Roell SA, Hulsbergen-Van de Kaa CA, Knipscheer BC, Witjes JA, Barentsz JO and Heerschap A: Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 245: 507-516, 2007.
5. Heijmink SW, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ, Hulsbergen-Van de Kaa CA, Knipscheer BC, Kiemeney LA, Witjes JA and Barentsz JO: Prostate cancer: body-Array versus endorectal coil MR imaging at 3.0 T -comparison of image quality, localization, and stafing performance. Radiology 244: 184-195, 2007.
6. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, and Choyke PL: Dynamic contrast enhanced MRI of prostate cancer at 3T: a study of pharmacokinetic parameters. Am J Roentgenol 189: 849-849, 2007.
7. Franiel T, Lüdemann L, Rudolph B, Rehbein H, Stephan C, Taupitz M and Beyersdorff D: Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 252: 101-108, 2009.
8. Roethke MC, Lichy MP, Jurgschat L, Hennenlotter J, Vogel U, Schilling D, Stenzl A, Claussen CD and Schlemmer HP: Tumorsize dependent detection rate of endorectal MRI of prostate cancer-A histopathologic correlation with whole-mount sections in 70 patients with prostate cancer. Eur J Radiol 79(2): 189-195, 2011.
9. Beyersdorf D, Taymoorian K, Knose T et al: MRI of the prostate cancer at 1.5 and 3.0T: comparison of image quality in tumor detection and staging. Am J Roentgenol 185: 1214-1220, 2005.
10. Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Wright AJ, Barentsz JO, Heerschap A and Scheenen TW: In vivo assessment of prostate cancer agressiveness using magnetic resonance spectroscopy imaging at 3 T with an endorectal coil. Eur Urol 60(5): 1074-1080, 2011.
11. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ and Choyke PL: Prostate cancer: value of multiparametric MR imaging at 3 T for detection -histopatologic correlation. Radiology 255: 89-99, 2010.
12. Klijn S, De Visschere PJ, De Meerleer GO and Villeirs GM: Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection. Eur J Radiol 81(3): 411-416, 2012.
13. Chabanova E, Balslev I, Logager V, Hansen A, Jakobsen H, Kromann-Andersen B, Norgaard N, Horn T and Thomsen HS: Prostate cancer: 1.5 T endo-coil dynamic contrast-enhanced MRI and MR spectroscopy-correlation with prostate biopsy and prostatectomy histopathological data. Eur J Radiol 80(2): 292-296, 2001.
14. Vilanova JC, Comet J, Barceló-Vidal C, Barceló J, López-Bonet E, Maroto A, Arzoz M, Moreno A and Areal J: Periphreal zone prostate cancer in patients with elevated PSA and low free-tototal PSA ratio: detection with MR imaging and MR spectroscopy. Radiology 253: 135-143, 2009.
15. Cornud F, Rouanne M, Beuvon F, Eiss D, Flam T, Liberatore M, Zerbib M and Delongchamps NB: Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? Eur J Radiol 81(4): e591-597, 2012.
16. Valentini AL, Gui B, Cina A, Pinto F, Totaro A, Pierconti F, Bassi PF and Bonomo L: T2-Wighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-histopathology correlations. Eur J Radiol 81(11): 3090-3095, 2012.
17. Isebaert S, De Keyzer F, Haustermans K, Lerut E, Roskams T, Roebben I, Van Poppel H, Joniau S and Oyen R: Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology. Eur J Radiol 81(3): e217-22, 2012.